VTVT — vTv Therapeutics Balance Sheet
0.000.00%
- $53.16m
- $6.10m
Annual balance sheet for vTv Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 1.78 | 5.75 | 13.4 | 12.1 | 9.45 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.005 | 0.158 | 0.057 | 12.4 | 0.102 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2.84 | 7.21 | 15.6 | 27.1 | 10.7 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1 | 0.849 | 0.68 | 0.556 | 0.361 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 9.27 | 14.8 | 25.5 | 33.2 | 11 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 13.4 | 6.39 | 8.5 | 7.71 | 10.6 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 58.3 | 94.9 | 35.2 | 44 | 35.7 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -49 | -80.1 | -9.74 | -10.7 | -24.7 |
Total Liabilities & Shareholders' Equity | 9.27 | 14.8 | 25.5 | 33.2 | 11 |
Total Common Shares Outstanding |